Saniona is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for patients suffering from rare diseases for which there are a lack of available treatment options.
Year founded2011
Served areaWorldwide
Headcount25
HeadquartersSmedeland 26B, 2600 Glostrup (Denmark) – Sweden
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
05.07.22 | Karl Johan Bertil Sundberg | Other | Buy | SEK 142,128.00 |
05.07.22 | Thomas Feldthus | Other | Buy | SEK 130,590.00 |
05.07.22 | Thomas Feldthus | Other | Buy | SEK 129,600.00 |
05.07.22 | Thomas Feldthus | Other | Buy | SEK 22,685.24 |
04.07.22 | Thomas Feldthus | Other | Buy | SEK 92,000.00 |
04.07.22 | Thomas Feldthus | Other | Buy | SEK 85,320.00 |
04.07.22 | Thomas Feldthus | Other | Buy | SEK 73,800.00 |
04.07.22 | Thomas Feldthus | Other | Buy | SEK 66,587.50 |
04.07.22 | Thomas Feldthus | Other | Buy | SEK 37,890.00 |
04.07.22 | Thomas Feldthus | Other | Buy | SEK 37,250.00 |
SE0005794617
LEI5493007EML562CPXRM34
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.